Table 3: Clinical information of SPK and RT transplantation groups.

TransplantationSPK ()RT ()

Pancreatic cold ischemic time (h), median (IQR)6 (6-7)
Renal cold ischemia time (h), median (IQR)4 (3–5)8 (5–9)0.000
HLA mismatch, median (IQR)2 (2-3)3.0 (2.0-3.3)0.693
Negative lymphocytotoxicity, n (%)19 (100)22 (100)
Immunosuppressive regimen, n (%)<0.001
 FK506 + MMF + Pred17 (89.5)3 (13.6)
 CsA + MMF + Pred2 (10.5)15 (68.2)
 RAPA + MMF + Pred0 (0.0)4 (18.2)
Induction regimen, n (%)<0.001
Simulect2 (10.5)20 (90.9)
ATG17 (89.5)2 (9.1)

SPK: simultaneous pancreas–kidney transplantation; RT: diabetic patients with uremia who underwent renal transplantation; HLA: human leucocyte antigen; FK506: tacrolimus; MMF: mycophenolate mofetil; Pred: prednisone; CsA: ciclosporin; RAPA: rapamycin; ATG: rabbit anti-human thymocyte globulin.